New method for measuring central venous pressure wins award

The company Veinpress GmbH won the CTI Swiss Medtech Award in Bern on Tuesday. The company was awarded the prize for a joint venture with ETH Zurich.

Enlarged view: Veinpress GmbH won the CTI Swiss Medtech Award
Orçun Göksel and Vincent Baumann with trophy and check. (Photo: Tom Kawara)

Gábor Székely, Head of CTI (Commission for Technology and Innovation) Medtech, presented Orçun Göksel, SNSF-Professor at the Department of Information Technology and Electrical Engineering at ETH Zurich and Vincent Baumann (Veinpress GmbH) with the award, which includes a check for more than CHF 10 000 and a trophy. Their project was selected from among three nominated projects by the audience of around 400 experts from the fields of Medtech research and industry.

Measuring venous pressure quickly

Central venous pressure (CVP) is an important medical parameter. It is measured every hour for specific medical conditions in intensive care units. CPV allows doctors to draw conclusions regarding the volume of blood in the vascular system. This is relevant in the case of haemorrhage, for example. CPV measurements currently require the insertion of a catheter, which is laborious, painful for the patient and can lead to serious complications.

A CTI Project facilitated the development of a software application for ultrasound measurement, which allows the measurement of CVP in real time independently of the patient. Peripheral venous pressure is measured using an elastic membrane, olive oil as a sound-conducting agent, an ultrasound probe and a measuring device. PVP correlates exactly with CVP. The principle works well. Compared with catheter measurements, the accuracy is 95 per cent. The product should allow for significant savings in healthcare. In addition to being much cheaper than a disposable catheter, the reusable Veinpress system does not cause complications.

CTI Medtech Initiative

The CTI Medtech Initiative was launched in 1997 and has since funded over 500 projects. CTI Medtech pursues two main objectives: to improve the innovativeness and competitiveness of Swiss medical technology and to stimulate the transfer of know-how between researchers, medical technology companies, start-up companies and SMEs. In 2013, CTI approved 29 projects and awarded federal grants amounting to CHF 9.6 million.

JavaScript has been disabled in your browser